The company's FDA-approved drug Sofdra is the first for the common and embarrassing condition of excessive sweating.

MA Moelis rates Carnaby a Buy with a high target, while RBC gives FireFly an Outperform rating on its Green Bay project.

Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds. In this episode, host Fraser Palamara ...

Stockhead’s ‘Garimpeiro’ columnist Barry FitzGerald is back in the studio for another instalment of The Explorers Podcast.

EBR Systems is among ASX healthcare stocks with upcoming catalysts, expecting feedback on a FDA substantive review expected ...

Bitcoin’s bounce to record highs in recent days is only the beginning of a fresh surge higher for crypto, says US billionaire ...

The Trump administration is expected to liberalise research into psychedelic-assisted therapies – and Emyria investors have ...

The US election failed to deliver extra Chinese stimulus measures companies had been banking on, affecting copper and iron ...

The ASX dipped again as mining and energy stocks fell, with Paladin Energy slashing its guidance and seeing shares drop more than 20pc.

Bitcoin tops record with bets on $100K by December, amid rumours of a nation-state quietly buying Bitcoin and US Bitcoin ...

Suvo aims to cut emissions in cement production with its green solution, targeting a potential trillion-dollar market.

Barring unforeseen rivals, Imricor will have a 100 per cent share of the MRI-guided cardiac catheter ablation market, writes ...